(f) Reflects adjustment for assumed corporate tax rate of 40%.
(g) Reflects depreciation & amortization of Chem Rx Corporation, excluding
contribution of 750 Park Place. 750 Park Place is an affiliate that
was not acquired in the transaction.
(h) Reflects 1) non-recurring expenses related to the operations of Chem
Rx Corporation prior to the acquisition of B.J.K. Inc. and 2) certain
professional fees and other expenses not related to the ongoing
operations of B.J.K. Inc.
Pro Forma Adjusted EBITDA is not a measurement of financial performance
under generally accepted accounting principles (GAAP) and should not be
considered as a measure of liquidity or as an alternative to operating
income, net income or cash flow from operating activities as indicators of
operating performance or any other measures of performance derived in
accordance with GAAP.
Chem Rx Corporation U.S. GAAP to Non-GAAP Measure Reconciliation
PRO FORMA ADJUSTED EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION &
AMORTIZATION (PRO FORMA ADJUSTED EBITDA)
For the Year Ended December 31, 2006
(Figures in thousands)
MANAGEMENT NON-GAAP U.S. GAAP NON-GAAP
MEASURES MEASURE PRO FORMA ADJUSTMENTS MEASURE
Chem Rx Chem Rx
Corporation B.J.K. Inc. Corporation
U.S. GAAP U.S. GAAP Non-GAAP
Period Ended Period Ended Non-GAAP Pro Forma
December 31, October 26, Other December 31,
2006 2006 Adjustments 2006
|SOURCE Chem Rx Corporation|
Copyright©2008 PR Newswire.
All rights reserved